Global MicroRNA Tools and Services Market Analysis 2018 - Forecast to 2023

Report ID : RC-1513 Category : Biotechnology Published Date : Oct-18
Publisher : 9Dimen Pages : 121 Format : PDF
Global MicroRNA Tools and Services Market Analysis 2018 - Forecast to 2023

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "MicroRNA Tools and Services". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2023 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 MicroRNA Tools and Services Market by Tools
5.1 Introduction
5.2 Microarrays
5.3 Quantitative Real Time PCR (qRT-PCR)
5.4 Next Generation Sequencing (NGS)
5.5 Northern Blotting
5.6 in situ Hybridization (ISH)
5.7 Hybridization-based Techniques
5.8 Functional Analysis Tools
5.8.1 miRNA Mimics
5.8.2 miRNA Inhibitors
6 MicroRNA Tools and Services Market by Services
6.1 Introduction
6.2 Expression Profiling and Analysis
6.3 Phenotypic Analysis
7 MicroRNA Tools and Services Market by Application
7.1 Introduction
7.2 Biomarkers
7.3 Pathology
7.4 Diagnostic
7.5 Therapeutic Applications
7.6 Nephrology
8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others
9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiles
10.1 Applied Biological Materials, Inc.
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Macrogen, Inc
10.3 Exiqon A/S
10.4 Life Technologies Corporation
10.5 Miltenyi Biotec GmbH
10.6 Dharmacon
10.7 Illumina, Inc.
10.8 Beijing Genomics Institute
10.9 Thermo Fisher Scientific Inc.
10.10 Bio-Rad Laboratories, Inc.
10.11 HTG Molecular Diagnostics, Inc
10.12 LC Sciences, LLC
10.13 Rosetta Genomics
10.14 Quanta BioSciences, Inc.
10.15 Promega Corporation
10.16 Integrated DNA Technologies
10.17 F. Hoffmann-La Roche AG
10.18 Toray Industries
10.19 Wako Pure Chemical Ind. Ltd.
10.20 WaferGen Bio-systems, Inc.

Sidebar Menu